By Bonnie Eslinger (June 5, 2023, 11:25 PM EDT) -- A former Gilead executive testifying Monday in an antitrust trial over claims Gilead and Teva illegally delayed generic versions of its blockbuster HIV drugs until 2020 told jurors that before the pharmaceutical makers' deal, Gilead executives discussed the possibility that generic competition for Truvada could come as early as 2017....
Adblock test (Why?)
Comments
Post a Comment